a post-hoc analysis of the prasinezumab trial in early parkinson's disease
Published 1 month ago • 131 plays • Length 13:48Download video MP4
Download video MP3
Similar videos
-
1:24
pasadena trial: prasinezumab in early parkinson's disease
-
2:53
padova study: prasinezumab in patients with early parkinson's disease
-
1:29
prasinezumab: an anti-alpha-synuclein antibody in parkinson's disease
-
1:49
learnings from the pasadena trial in parkinson's disease
-
0:18
trap: symptoms of parkinson disease | medical mnemonic | merck manual professional version
-
1:37
the role of neuroinflammatory responses in parkinson’s disease
-
19:02
nvjc ep. 16 parkinson disease /movement disorders collection: association of csf glucocerebrosidase
-
4:42
parkinson and other movement disorders center at uc san diego health
-
1:14
parkinson's disease and clinical trials
-
8:15
pasadena prasinezumab 12 month data
-
33:49
could prasinezumab be reducing motor progression in the pasadena open-label extension? -rallying 23
-
14:04
parkinson’s disease: new developments and therapies - on our mind
-
1:12:27
moving forward: clinical trials in parkinson's disease
-
3:23:27
p1 - parkinson disease & related problems (indo-china movement disorders conference 2022)
-
6:02
the parkinson's disease and movement disorders center | 2019 udall center research symposium
-
46:26
oral history 2012: mark hallett interviews joseph jankovic
-
6:25
parkinson's disease comprehensive care